Skip to Content

Notice

Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children; Notice of Meeting

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Public Law 92-463), notice is hereby given of the following meeting:

Name: Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children (ACHDGDNC).

Dates and Times:

September 22, 2004, 9 a.m. to 5 p.m.

September 23, 2004, 9 a.m. to 5 p.m.

Place: Jurys Washington Hotel, 1500 New Hampshire Avenue, NW., Washington, DC 20036. Phone: 202-483-6000. Fax: 202-328-3265. http://www.jurysdoyle.com.

Status: The meeting will be open to the public with attendance limited to space availability.

Purpose: The Advisory Committee provides advice and recommendations concerning the grants and projects authorized under the Heritable Disorders Program and technical information to develop policies and priorities for this program that will enhance the ability of the State and local health agencies to provide for newborn and child screening, counseling and health care services for newborns and children having or at risk for heritable disorders. Specifically, the Committee shall advise and guide the Secretary regarding the most appropriate application of universal newborn screening tests, technologies, policies, guidelines and programs for effectively reducing morbidity and mortality in newborns and children having or at risk for heritable disorders.

Agenda: The first day will be devoted to presentations on the following: A report from the American College of Medical Genetics, followed by a discussion; new and evolving technologies that State newborn screening programs may be using in the near future; and the status of tandem mass spectrometry in States and barriers to expansion with this technology. The second day will be devoted to presentations on analyses of the cost and benefit of newborn screening and the financing mechanisms for State newborn screening programs.

Proposed agenda items are subject to change as priorities indicate.

Time will be provided each day for public comment. Individuals who wish to provide public comment or who plan to attend the meeting and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the ACHDGDNC Executive Secretary, Michele A. Lloyd-Puryear, M.D., Ph.D. (contact information provided below).

Contact Person: Anyone interested in obtaining a roster of members or other relevant information should write or contact Michele A. Lloyd-Puryear, M.D., Ph.D., Maternal and Child Health Bureau, Health Resources and Services Administration, Room 18-20, Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857, telephone (301) 443-1080. Information on the Advisory Committee is available at http://mchb.hrsa.gov/​programs/​genetics/​committee.

Start Signature

Dated: July 16, 2004.

Tina M. Cheatham,

Director, Division of Policy Review and Coordination.

End Signature End Preamble

[FR Doc. 04-16874 Filed 7-23-04; 8:45 am]

BILLING CODE 4165-15-P